MITCHELL WOODS PHARMACEUTICALS Trademark

Trademark Overview


On Tuesday, May 1, 2018, a trademark application was filed for MITCHELL WOODS PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the MITCHELL WOODS PHARMACEUTICALS trademark a serial number of 87901720. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 15, 2019. This trademark is owned by Mitchell Woods Pharmaceuticals, Inc.. The MITCHELL WOODS PHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, autoimmune, neurological, cancer, hematological, inflammatory, respiratory, and transplantation related diseases and disorders

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the field of pharmaceuticals for the treatment of cardiovascular, autoimmune, neurological, cancer, hematological, inflammatory, respiratory, and transplantation related diseases and disorders
mitchell woods pharmaceuticals

General Information


Serial Number87901720
Word MarkMITCHELL WOODS PHARMACEUTICALS
Filing DateTuesday, May 1, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 15, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2018

Trademark Statements


Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, autoimmune, neurological, cancer, hematological, inflammatory, respiratory, and transplantation related diseases and disorders
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the field of pharmaceuticals for the treatment of cardiovascular, autoimmune, neurological, cancer, hematological, inflammatory, respiratory, and transplantation related diseases and disorders
Name/Portrait Description and/or Consent StatementThe name shown in the mark does not identify a particular living individual.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 9, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMitchell Woods Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShelton, CT 06484

Party NameMitchell Woods Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShelton, CT 06484

Trademark Events


Event DateEvent Description
Monday, July 15, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 15, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 6, 2018ASSIGNED TO LIE
Thursday, August 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 23, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, August 23, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 23, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, August 23, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 22, 2018ASSIGNED TO EXAMINER
Wednesday, May 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 4, 2018NEW APPLICATION ENTERED IN TRAM